Ferumoxytol Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 30 mg/mL

Reference Brands: Feraheme (USA)

Category: Anemia

Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, especially in adults with chronic kidney disease. It is available as a 30 mg/mL IV solution, supplied in 17 mL vials (510 mg elemental iron). In the USA, both brand and generic versions are available. Ferumoxytol Injection is available in Injection and strengths such as 30 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ferumoxytol Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ferumoxytol Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Iron deficiency anemia during pregnancy is a common nutritional disorder that can significantly affect both maternal health and fetal development. Adequate iron levels are essential during pregnancy, particularly because the developing fetus requires sufficient iron for proper brain growth and neurological development. When a mother experiences iron deficiency, especially during the second and third trimesters, the amount of iron transferred to the fetus may be limited. This can potentially affect fetal development, as iron plays a critical role in oxygen transport, brain maturation, and cellular metabolism.

Research has shown that prenatal iron deficiency may be associated with adverse outcomes related to fetal brain development and long-term neurological health. Because of these risks, maintaining proper iron levels during pregnancy is considered an important part of prenatal care.

Oral iron supplements are commonly used to treat iron deficiency anemia; however, they may sometimes cause gastrointestinal side effects such as nausea, constipation, or stomach discomfort. In cases where oral iron is poorly tolerated or insufficient, intravenous iron therapy may be considered. Intravenous formulations, such as iron sucrose, have been widely used to replenish iron stores safely and effectively. Newer intravenous iron formulations can deliver higher doses in fewer administrations, allowing more efficient correction of iron deficiency while reducing the number of treatment visits required.